How 23andMe’s gene-testing dream turned recessive
She has resigned from the former; the latter does not matter since 23andMe’s equity could be wiped out. If persistence pays off, a company that started out as little more than an intriguing idea and a ...
Reuters6d
Corporate Structure
Mallinckrodt and Endo are exploring a potential merger that could be valued at about $7 billion, person familiar with the matter told Reuters on Wednesday. Healthcare & Pharmaceuticalscategory ...
Endo, Inc.: Endo Presents Dupuytren Contracture Data at the IFSSH and IFSHT Triennial Congress
Endo, Inc. (OTCQX: NDOI) announced today that data related to the use of XIAFLEX® (collagenase clostridium histolyticum, or CCH) for the treatment ...
Reuters5d
Kroger countersues rival Albertsons after demise of $25 billion merger
Albertsons terminated the merger immediately after courts blocked it and sued Kroger, alleging a breach of contract that led to the deal falling apart. Sign up here. The formal termination ended a ...
pharmaphorum5d
Mallinckrodt's long haul with terlipressin in US ends in approval
Mallinckrodt has finally claimed FDA approval for terlipressin as a treatment for hepatorenal syndrome (HRS), after manufacturing problems scuppered an earlier attempt. Terlipressin – now given ...
Investopedia3d
Are Workplaces Getting More Toxic? Some Employees Think So
Jordyn joined Investopedia in February 2025. She was previously a freelance writer covering lifestyle, entertainment, politics in the Midwest, and more. Getty Images A new survey dove into the ...
pharmaphorum3d
Troubled Mallinckrodt pays $1.2bn for Sucampo
Specialist pharma company Mallinckrodt announced on 26 December that it is to acquire Sucampo Pharmaceuticals for around $1.2 billion. The company’s management are clearly looking to bring cheer ...